Cottagnoud P, Gerber C M, Acosta F, Cottagnoud M, Neftel K, Täuber M G
Department of Internal Medicine, Inselspital, Freiburgstrasse, 3010 Berne, Switzerland.
J Antimicrob Chemother. 2000 Dec;46(6):981-5. doi: 10.1093/jac/46.6.981.
Linezolid, a new oxazolidinone antibiotic, showed good penetration (38+/-4%) into the meninges of rabbits with levels in the CSF ranging from 9.5 to 1.8 mg/L after two i.v. injections (20 mg/kg). Linezolid was clearly less effective than ceftriaxone against a penicillin-sensitive pneumococcal strain. Against a penicillin-resistant strain, linezolid had slightly inferior killing rates compared with the standard regimen (ceftriaxone combined with vancomycin). In vitro, linezolid was marginally bactericidal at concentrations above the MIC (5 x and 10 x MIC).
利奈唑胺是一种新型恶唑烷酮类抗生素,在给家兔静脉注射两次(20mg/kg)后,它在兔脑膜中显示出良好的穿透性(38±4%),脑脊液中的浓度范围为9.5至1.8mg/L。在针对青霉素敏感肺炎球菌菌株方面,利奈唑胺的效果明显不如头孢曲松。在针对青霉素耐药菌株时,与标准治疗方案(头孢曲松联合万古霉素)相比,利奈唑胺的杀菌率略低。在体外,当浓度高于最低抑菌浓度(5倍和10倍最低抑菌浓度)时,利奈唑胺具有微弱的杀菌作用。